Literature DB >> 12784187

Insulin-like effect of low-dose leptin on glucose transport in Langendorff rat hearts.

M Haap1, B Houdali, E Maerker, W Renn, F Machicao, H M Hoffmeister, H-U Häring, K Rett.   

Abstract

BACKGROUND: In a murine myotube cell line (C 2 C 12 myotubes), leptin at low physiological concentrations (1 ng/ml) has been shown to stimulate glucose transport and glycogen synthesis. The aim of the present study was to test whether an analogous leptin effect on glucose transport is detectable in the heart. METHODS AND
RESULTS: We used the isolated Langendorff rat heart preparation with hemodynamic function control. Using polymerase chain reaction (RT-PCR), a 346- and 375-base fragment indicative for the short and long leptin receptor isoform was detected in the rat heart. Glucose transport rates were calculated using equimolar double tracer perfusion with the non-metabolizable glucose analog 3-O-methylglucose (3-O-MG) and the non-transportable tracer mannitol and two-compartimental modeling. 3-O-MG uptake at a perfusate glucose concentration of 11 mM was measured over 15 minutes in control hearts, hearts perfused with insulin (10 mU/ml), leptin (1 ng/ml) or insulin (10 mU/ml) plus leptin (1 ng/ml; n = 8 in each group). The basal 3-O-MG transport rate of 0,7351 +/- 0,051 micro mol/min/g wet weight was increased 4.18 fold with insulin, 2.69 fold with leptin, and 4.2 fold with leptin plus insulin. Simultaneous monitoring of hemodynamic function revealed a minor and transient effect of leptin on left ventricular pressure, which was strongly augmented in coperfusion with insulin.
CONCLUSIONS: The data suggest that leptin at low physiological concentrations is able to exert a partial insulin like effect on glucose uptake. We speculate that the effect might be mediated by both leptin receptor isoforms. This leptin effect is additive to the effect of insulin and might therefore contribute to the insulin independent basal glucose supply of the heart. It can not be completely excluded that the observed leptin effect on glucose transport is secondary to altered myocardial function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12784187     DOI: 10.1055/s-2003-39786

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  7 in total

Review 1.  Cardiovascular effects of leptin.

Authors:  Gary Sweeney
Journal:  Nat Rev Cardiol       Date:  2009-12-01       Impact factor: 32.419

Review 2.  Diabetic cardiomyopathy: signaling defects and therapeutic approaches.

Authors:  Joseph S Dobrin; Djamel Lebeche
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-03

3.  Hyperglycemia, impaired glucose tolerance and elevated glycated hemoglobin levels in a long-lived mouse stock.

Authors:  James M Harper; Stephen J Durkee; Michael Smith-Wheelock; Richard A Miller
Journal:  Exp Gerontol       Date:  2005-04       Impact factor: 4.032

4.  Changes in cardiac energy metabolic pathways in overweighed rats fed a high-fat diet.

Authors:  Javier Modrego; Natalia de las Heras; Jose J Zamorano-León; Petra J Mateos-Cáceres; Beatriz Martín-Fernández; Maria Valero-Muñoz; Vicente Lahera; Antonio J López-Farré
Journal:  Eur J Nutr       Date:  2012-06-14       Impact factor: 5.614

Review 5.  Lean heart: Role of leptin in cardiac hypertrophy and metabolism.

Authors:  Michael E Hall; Romain Harmancey; David E Stec
Journal:  World J Cardiol       Date:  2015-09-26

6.  Cardiomyocyte-specific deletion of leptin receptors causes lethal heart failure in Cre-recombinase-mediated cardiotoxicity.

Authors:  Michael E Hall; Grant Smith; John E Hall; David E Stec
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-31       Impact factor: 3.619

7.  Chronic CNS-mediated cardiometabolic actions of leptin: potential role of sex differences.

Authors:  Alexandre A da Silva; Mark A Pinkerton; Frank T Spradley; Ana C Palei; John E Hall; Jussara M do Carmo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-11-18       Impact factor: 3.619

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.